(Total Views: 549)
Posted On: 07/21/2020 8:13:25 AM
Post# of 145880
![](/m/assets/46931549/no_avatar_available_thumb.jpg)
Does anyone know whether 2:1 dosing in favor of Leronlimab although it seems to help the safety argument at the same time degrade the efficacy claim? I’m not a statistician...anyone?
![](/m/images/thumb-up.png)
![](/m/images/thumb-down.png)